RIG
44
-2
DRI
56
2
ROK
67
5
MPC
47
3
ALLE
41
-7
SHW
70
2
GS
75
-4
IFF
53
2
TRV
56
-2
SLG
62
-4
RRC
60
-3
SYY
47
-2
PAYX
57
-2
NOC
40
-10
NI
73
3
HES
66
3
AON
60
2
NOV
58
-2
ADI
45
-5
CHRW
67
3
RIG
44
-2
DRI
56
2
ROK
67
5
MPC
47
3
ALLE
41
-7
SHW
70
2
GS
75
-4
IFF
53
2
TRV
56
-2
SLG
62
-4
RRC
60
-3
SYY
47
-2
PAYX
57
-2
NOC
40
-10
NI
73
3
HES
66
3
AON
60
2
NOV
58
-2
ADI
45
-5
CHRW
67
3
Financhill
Back

Beam Therapeutics Quote, Financials, Valuation and Earnings

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.
Buy
73

BEAM
Beam Therapeutics

Last Price:
26.31
Seasonality Move:
54.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump wins! Dow to 75,000? Details here

See the explosive "Document 20" details here.

Beam Therapeutics Price Quote

$26.31
-1.19 (-4.33%)
(Updated: November 14, 2024 at 5:55 PM ET)

Beam Therapeutics Key Stats

Buy
73
Beam Therapeutics (BEAM) is a Buy
Day range:
$27.15 - $28.91
52-week range:
$20.84 - $49.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.54
P/B ratio:
2.92%
Volume:
819.8K
Avg. volume:
1.1M
1-year change:
25.34%
Market cap:
$2.3B
Revenue:
$377.7M
EPS:
$-1.76

How Much Does Beam Therapeutics Make?

Is Beam Therapeutics Growing As A Company?

  • What Is Beam Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.17%
  • What Is Beam Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Beam Therapeutics Stock Price Performance

What Is Beam Therapeutics 52-Week High & Low?

Beam Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Beam Therapeutics?

  • How Much Debt Does Beam Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Beam Therapeutics Have?
    Cash and short term investments quarterly total is $925.8M
  • What Is Beam Therapeutics’s Book Value Per Share?
    Book value per share is 9.58

Is Beam Therapeutics Cash Flow Positive?

  • What Is BEAM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$135.8M
  • What Is Beam Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $38M
  • What Is Beam Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $156.8M

Beam Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    BEAM return on invested capital is -16.62%
  • What Is Beam Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -10.97%
  • What Is BEAM Return On Equity?
    ROE is a measure of profitability and is -16.62%

Beam Therapeutics Earnings Date & Stock Price

Beam Therapeutics Competitors

Beam Therapeutics Dividend Yield

Beam Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0.93%
Revenue: -17.01% 0.97%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 8
Sell Recommendations: 0
Price Target: 49.20
Upside from Last Price: 78.91%

Major Shareholders

  • How many BEAM shares are owned by institutional investors?
    123.4M BEAM shares are owned by institutional investors
  • How many BEAM shares are owned by insiders?
    1.5M BEAM shares are owned by insiders